
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update
Yu Wang, Ying‐Jun Chang, Jing Chen, et al.
Cancer Letters (2024) Vol. 605, pp. 217264-217264
Closed Access | Times Cited: 16
Yu Wang, Ying‐Jun Chang, Jing Chen, et al.
Cancer Letters (2024) Vol. 605, pp. 217264-217264
Closed Access | Times Cited: 16
Showing 16 citing articles:
Clinical features and prognostic nomogram for therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Menglin Li, Yimeng Li, Qingyuan Qu, et al.
Cancer Letters (2025), pp. 217460-217460
Closed Access | Times Cited: 2
Menglin Li, Yimeng Li, Qingyuan Qu, et al.
Cancer Letters (2025), pp. 217460-217460
Closed Access | Times Cited: 2
Haploidentical peripheral blood stem cells combined with bone marrow or unrelated cord blood as grafts for haematological malignancies: an open-label, multicentre, randomised, phase 3 trial
Sijian Yu, Fen Huang, Na Xu, et al.
The Lancet Haematology (2025)
Closed Access | Times Cited: 1
Sijian Yu, Fen Huang, Na Xu, et al.
The Lancet Haematology (2025)
Closed Access | Times Cited: 1
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive acute lymphoblastic leukemia
Jun Kong, Fengmei Zheng, Chen‐Hua Yan, et al.
Annals of Hematology (2025)
Open Access
Jun Kong, Fengmei Zheng, Chen‐Hua Yan, et al.
Annals of Hematology (2025)
Open Access
Impact of TP53 alteration on allogeneic hematopoietic cell transplantation outcomes for myelodysplastic syndromes
Cuiyan Zhou, Lan‐Ping Xu, Xiaohui Zhang, et al.
Bone Marrow Transplantation (2025)
Closed Access
Cuiyan Zhou, Lan‐Ping Xu, Xiaohui Zhang, et al.
Bone Marrow Transplantation (2025)
Closed Access
A novel reduced toxicity conditioning regimen for older myelodysplastic neoplasms patients undergoing haploidentical stem cell transplantation: a prospective cohort study
Wenjing Yu, Yu‐Qian Sun, Xiao-Hui Zhang, et al.
American Journal of Cancer Research (2025) Vol. 15, Iss. 1, pp. 182-194
Closed Access
Wenjing Yu, Yu‐Qian Sun, Xiao-Hui Zhang, et al.
American Journal of Cancer Research (2025) Vol. 15, Iss. 1, pp. 182-194
Closed Access
Translational study of the regulatory mechanism by which immune synapses enhance immune cell function
Yahui Li, Xiao‐Jun Huang, Xiang‐Yu Zhao
Cancer Letters (2025) Vol. 614, pp. 217542-217542
Closed Access
Yahui Li, Xiao‐Jun Huang, Xiang‐Yu Zhao
Cancer Letters (2025) Vol. 614, pp. 217542-217542
Closed Access
Effect of Age, Sex and Season on Acute Myeloid Leukemia Clinical Characteristics: A Retrospective Study
Xingyu Wan, Tinglu Tao, Jing Zhang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2363-2375
Open Access
Xingyu Wan, Tinglu Tao, Jing Zhang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2363-2375
Open Access
Evaluation and preservation of fertility in patients with hematologic malignancies
Xuan Wang, Ruihao Huang, Lei Liu, et al.
Cancer Letters (2025), pp. 217569-217569
Open Access
Xuan Wang, Ruihao Huang, Lei Liu, et al.
Cancer Letters (2025), pp. 217569-217569
Open Access
piRNAs in leukemogenesis: Mechanisms, biomarkers, and therapeutic implications
Gaurav Gupta, Muhammad Afzal, Ahsas Goyal, et al.
Clinica Chimica Acta (2025), pp. 120220-120220
Closed Access
Gaurav Gupta, Muhammad Afzal, Ahsas Goyal, et al.
Clinica Chimica Acta (2025), pp. 120220-120220
Closed Access
Allogeneic versus autologous hematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: a real-world multicenter analysis in China
Yuewen Wang, Weiping Liu, Zhenyang Gu, et al.
Cancer Letters (2025), pp. 217664-217664
Closed Access
Yuewen Wang, Weiping Liu, Zhenyang Gu, et al.
Cancer Letters (2025), pp. 217664-217664
Closed Access
Stem cell transplantation indications for patients with acute leukemia determined by measurable residual disease: what we know and what we do not know
Xiaosu Zhao, Xiaotong Chen, Ying‐Jun Chang
Blood Science (2025) Vol. 7, Iss. 2, pp. e00229-e00229
Open Access
Xiaosu Zhao, Xiaotong Chen, Ying‐Jun Chang
Blood Science (2025) Vol. 7, Iss. 2, pp. e00229-e00229
Open Access
Comparable Survival Outcomes in HLA-Matched and Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Patients Aged 40-50: A CBMTR Registry-Based Propensity Score Matching Analysis Over the Last Decade
Zhengli Xu, Yuping Zhang, Baodong Ye, et al.
Cancer Letters (2025), pp. 217594-217594
Closed Access
Zhengli Xu, Yuping Zhang, Baodong Ye, et al.
Cancer Letters (2025), pp. 217594-217594
Closed Access
Acute Myeloid Leukemia with Normal Cytogenetics and NPM1-Mutation: Impact of Mutation Topography on Outcomes
Mingyue Zhao, Ming-Yue Liao, Robert Peter Gale, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2921-2921
Open Access | Times Cited: 1
Mingyue Zhao, Ming-Yue Liao, Robert Peter Gale, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2921-2921
Open Access | Times Cited: 1
Intensified conditioning containing decitabine versus standard myeloablative conditioning for adult patients with KMT2A-rearranged leukemia: a multicenter retrospective study
Zhongli Hu, Zinan Feng, Shiqi Liu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access
Zhongli Hu, Zinan Feng, Shiqi Liu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access
Clinical Features and Prognostic Nomogram for Therapy-Related Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Menglin Li, Yimeng Li, Qingyuan Qu, et al.
(2024)
Closed Access
Menglin Li, Yimeng Li, Qingyuan Qu, et al.
(2024)
Closed Access
Treatment of minimal residual disease in myeloid malignancies after allo-HSCT with venetoclax-based regimens in patients ineligible for or failed in the immunotherapy
Wenjing Yu, Jun Kong, Fengmei Zheng, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access
Wenjing Yu, Jun Kong, Fengmei Zheng, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access